Ocimum Labs

CAS 112101-77-6

Chemistry, 1 End Use API, 11 Related Intermediates

Manufacturers/Suppliers

1 Suppliers

1 Suppliers

Also known as: 112101-77-6, (s)-3-(4'-methoxy-3'-sulfonamidophenyl)-2-propylamine hydrochloride, (s)-3-(4 inverted exclamation mark -methoxy-3 inverted exclamation mark -sulfonamidophenyl)-2-propylamine hydrochloride

Molecular Formula

C₁₀H₁₇ClN₂O₃S

Molecular Weight

280.77 g/mol

InChI Key

KYRRNJIOCLALJQ-FJXQXJEOSA-N

1 2D Structure

CAS 112101-77-6

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[(2S)-2-aminopropyl]-2-methoxybenzenesulfonamide;hydrochloride

2.1.2 InChI

InChI=1S/C10H16N2O3S.ClH/c1-7(11)5-8-3-4-9(15-2)10(6-8)16(12,13)14;/h3-4,6-7H,5,11H2,1-2H3,(H2,12,13,14);1H/t7-;/m0./s1

2.1.3 InChI Key

KYRRNJIOCLALJQ-FJXQXJEOSA-N

2.1.4 Canonical SMILES

CC(CC1=CC(=C(C=C1)OC)S(=O)(=O)N)N.Cl

2.1.5 Isomeric SMILES

C[C@@H](CC1=CC(=C(C=C1)OC)S(=O)(=O)N)N.Cl

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 112101-77-6

2. (s)-3-(4'-methoxy-3'-sulfonamidophenyl)-2-propylamine Hydrochloride

3. (s)-3-(4 Inverted Exclamation Mark -methoxy-3 Inverted Exclamation Mark -sulfonamidophenyl)-2-propylamine Hydrochloride

2.3 Create Date

2007-02-08

3 Chemical and Physical Properties

Molecular Formula	C₁₀H₁₇ClN₂O₃S
Molecular Weight	280.77 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	4
Exact Mass	280.0648413 g/mol
Monoisotopic Mass	280.0648413 g/mol
Topological Polar Surface Area	104 Å²
Heavy Atom Count	17
Formal Charge	0
Complexity	313
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

India

Virtual Booth

Digital Content

R-(-)-5-(2-Amino-propyl)-2-methoxy-benzenesulfonamide

PDF Supplier PDF

URL Supplier Web Content

CAS Number

112101-81-2

End Use API

Tamsulosin

About the Company

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...

Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.

ASK
US